Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher
Go back to Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 65.92 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.92 | 52 Week High | $8.22 | |||
| Open | $65.92 | 52 Week Low | $3.07 | |||
| Day High | $65.92 | P/E | N/A | |||
| Day Low | $65.92 | EPS | $-1.30 | |||
| Volume | 70 | |||||
